After more than a decade with no new medications for chronic spontaneous urticaria, clinicians are beginning to see rapid ...
A small case-control study linked higher Dietary Inflammatory Index scores with progressive vitiligo, suggesting that ...
In ‘A Milestone in Vitiligo: Clinical Efficacy and Long-Term Repigmentation Trends,’ the expert dermatologist examined the following critical questions: In ‘A Milestone in Vitiligo: Clinical Efficacy ...
Broker Bell Potter dubs skin disorders specialist Clinuvel Pharmaceuticals' (ASX:CUV) upcoming phase III vitiligo study results as “one of 2026’s most keenly awaited ASX biotech readouts”.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results